2026 Health System Financial Priorities and the Impact on Commercial Strategy
Health system financial priorities in 2026 center on one posture: drive efficiency now, do not wait for policy clarity to act.
Across our proprietary 2026 Executive Priorities Survey, the finance leaders who set spending direction at the nation's largest health systems describe an environment of compressed margins, escalating costs, and federal policy volatility unlike anything they have managed before.
For commercial leaders at healthcare companies that sell into these systems, that posture changes everything about how a relationship begins and how a solution earns consideration. This piece draws on our Chief Financial Officer and Chief Revenue Cycle Officer persona research to explain what finance leaders are prioritizing, and how industry partners can position their commercial strategy to meet them where they already stand.
The 2026 Financial Landscape: Thin Margins, Rising Costs, and Policy Volatility
The financial backdrop for health systems in 2026 is defined by structural pressure rather than cyclical strain. Many health systems are operating on margins as low as 1.6 percent, which leaves almost no cushion to absorb new costs or revenue disruption. Costs themselves have climbed sharply: healthcare organizations have faced a compounded price increase of roughly 22 percent across drugs, medical supplies, and labor between 2020 and 2025, while Medicare reimbursement rates have declined approximately 10.4 percent over the same period. The result is a widening gap between what it costs to deliver care and what systems are paid for it.
Public policy adds a second layer of uncertainty. Medicaid cuts, premium tax credit expiration, and ongoing 340B reform are increasing financial pressures across the healthcare system, and they create volatile payer mixes that complicate forecasting. Uncompensated care now represents hundreds of millions in annual losses at some organizations. One Chief Financial Officer in our research compared the present moment to the creation of Medicare and diagnosis-related groups, describing it as the most change he has witnessed in his career.
For commercial teams, the takeaway is direct. Finance leaders are not framing this period as a reason to pause investment; they are treating efficiency as a survival imperative and acting in spite of the uncertainty. A value proposition built around helping systems maintain financial stability through measurable efficiency gains will land more credibly than one built around waiting for the landscape to settle.
What CFOs are Prioritizing, and What it Signals to Commercial Partners
Chief Financial Officers at Leading Health Systems are the senior-most finance leaders, reporting directly to the CEO and owning budgeting, capital allocation, and long-term financial sustainability. According to our 2026 survey of Leading Health System CFOs, several priorities stand out, and each one carries a signal for how commercial organizations should shape their approach.
Efficiency as the Primary Hedge
CFOs are targeting more than $100 million in two-year cost savings through supply chain optimization, automation, and clinical variation reduction. They have institutionalized accountability through frequent review meetings. A solution that demonstrates verifiable cost savings against a clear timeline speaks to this priority far better than one positioned on innovation alone.
AI Moving from Administrative Wins to Clinical Inflection
Artificial intelligence is already mature in revenue cycle, call centers, and clinical documentation, where it can reduce documentation time by 60 to 70 percent for clinicians. CFOs now want to inflect the clinical side, where a larger share of total cost resides. Commercial leaders should recognize that finance executives already have an AI strategy; the credible conversation is about ROI and clinical impact, not discovery.
Portfolio, Geography, and Payer Mix
CFOs are reassessing service-line profitability, market position, and payer mix to ensure sufficient commercial coverage. This reassessment of organizational priorities means commercial partners who help systems allocate resources effectively, or who enable capital-light expansion and partnership structures, are aligned with where strategic planning is actually heading.
When CFOs evaluate a solution, our research shows a consistent checklist: it must deliver measurable efficiency gains and reduce administrative burden, present a clear ROI timeline with a proven track record, scale across current assets with flexibility for growth, and enable capital-light expansion. Commercial strategies that map cleanly to these four tests earn a meeting; those that do not tend to stall in procurement.
What CRCOs are Defending, and Where Revenue Cycle Creates Openings
Chief Revenue Cycle Officers own the conversion of patient encounters into collected revenue, spanning patient access, coding, billing, claims management, denials, and payer contracting. They typically report to the CFO and increasingly partner with Government Relations. Their 2026 priorities reveal a leader fighting to protect revenue on several fronts at once, which shapes how commercial partners should engage.
Escalating Payer Tactics
Payers are shifting from outright denials toward retrospective DRG downgrades and recoupments, extending appeal timelines to six months or longer. CRCOs describe payer relationships that have deteriorated into repetitive, unproductive cycles, with no improvement in denial rates despite high appeal success rates. They are investing in legal escalation, case-rate contracting, and industry partnerships in response. Solutions that enable real-time payer accountability tracking address this pain directly.
Rising Uncompensated Care
As uncompensated care climbs to as high as 20 percent of revenue at some systems, CRCOs are redesigning front-end financial engagement. They are deploying pre-service payment plans, tightening eligibility verification, and using financial navigation tools to connect patients with assistance before balances become write-offs. Commercial teams supporting proactive patient financial engagement are working in step with this effort.
Offshoring as a Bridge to AI and Automation
CRCOs have moved past firm objections to offshoring, viewing it as a temporary bridge toward artificial intelligence and automation. They are structuring short-term contracts to preserve optionality while they evaluate AI for prior authorization, appeal generation, and coding optimization, with cybersecurity as their leading concern. The commercial implication is important: solutions that reduce manual dependency while preserving optionality as AI and Epic-native capabilities mature will resonate, whereas long lock-in contracts will meet resistance.
The CRCO solution checklist mirrors this reality. A solution earns consideration when it delivers measurable cost-to-collect reductions with transparent, verifiable ROI, enables payer accountability tracking, reduces manual dependency without foreclosing future options, and supports patient financial engagement that prevents write-offs before they occur.
The Financial Management Mechanics Buyers Care About
Commercial leaders build more credible relationships when they can speak fluently about the financial management mechanics their buyers manage every day. The following components recur across our CFO and CRCO research, and they form the operational vocabulary finance leaders expect a serious partner to understand.
Revenue cycle management and liquidity. Efficient revenue cycle management helps systems maintain sufficient liquid assets, and accurate billing and coding prevent claim rejections and underpayments. Regularly reviewing the revenue cycle identifies bottlenecks for improvement, which is why ongoing monitoring of claims processing and payments sits near the top of operational attention.
Doing more with existing resources. Rather than adding headcount, many health systems are focused on maximizing existing resources. Conducting cost-benefit analyses helps determine priorities across competing projects, and outsourcing select non-clinical operations can lower overhead and operational costs.
Analytics applied to staffing and supply. Predictive analytics can streamline workforce management and supply chain management, while AI-enabled scheduling tools help align staffing with patient demand. Dynamic staffing adjustments, in turn, reduce reliance on premium-priced agency nurses, a meaningful lever for managing costs.
Liquidity and time horizon. Given public policy uncertainties, health systems need to maintain stronger liquid reserves. Financial leaders concentrate on immediate cash flow and cost control to handle short-term disruptions, even as they balance those needs against long-term investments in digital health, telehealth, and preventive care that reduce total cost of care over time.
Each of these mechanics connects to the same underlying goal: directing limited financial resources toward the areas of highest impact so the organization can achieve its strategic objectives without compromising high-quality care.
Translating Financial Priorities Into Commercial Strategy
For VPs and above in commercial, market access, and strategy roles, the practical question is how to convert this understanding into a stronger commercial strategy. Three adjustments follow naturally from the research.
First, lead with verifiable ROI and total cost of care rather than features. Both CFOs and CRCOs evaluate solutions against a clear return timeline and a proven track record, so financial analysis and documented outcomes should anchor the conversation. Second, respect the genuine tension between short-term cash flow and long-term technology investments. A partner who acknowledges that finance leaders must protect immediate financial performance while investing in medical technologies for the future demonstrates fluency in the real constraint. Third, position your solution against the priorities finance leaders have already named. When a value proposition maps to denials management, automation of workflows, maximizing revenue capture, or capital-light expansion, it meets organizational priorities head-on instead of asking the buyer to translate.
The common thread is alignment. Commercial organizations that frame their offering in terms of how it helps a health system achieve financial sustainability, manage rising costs, and protect financial viability will find a more receptive audience than those leading with the product itself.
Explore our full persona research to understand these leaders in greater depth: the Chief Financial Officer persona and the Chief Revenue Cycle Officer persona.
How These Relationships Get Built: Executive Convening
Understanding financial priorities is the starting point. Building the trusted relationships that turn understanding into partnership is the harder work, and it is where our community creates distinct value. Through Executive Convening, we bring health system finance leaders and industry executives together in small, retreat-style forums built for peer-level dialogue rather than transactional networking. These programs give commercial leaders direct market insight into health system strategy, the strategic relationships that mature into long-term partnerships, and the opportunity to contribute thought leadership to the conversations shaping healthcare finance.
For organizations whose growth depends on credibility with finance executives, this access matters. Our financial healthcare conferences convene CFOs, CRCOs, and the broader finance leadership community around the challenges described throughout this article, and they are designed for leaders who value focused, closed-door discussion over the conference-hall floor.